474 related articles for article (PubMed ID: 12736199)
1. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
Martin PT
Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
3. Localization of the dystrophin binding site at the carboxyl terminus of beta-dystroglycan.
Rosa G; Ceccarini M; Cavaldesi M; Zini M; Petrucci TC
Biochem Biophys Res Commun; 1996 Jun; 223(2):272-7. PubMed ID: 8670271
[TBL] [Abstract][Full Text] [Related]
4. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers.
Ohlendieck K
Eur J Cell Biol; 1996 Jan; 69(1):1-10. PubMed ID: 8825019
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural localization of adhalin, alpha-dystroglycan and merosin in normal and dystrophic muscle.
Cullen MJ; Walsh J; Roberds SL; Campbell KP
Neuropathol Appl Neurobiol; 1996 Feb; 22(1):30-7. PubMed ID: 8866780
[TBL] [Abstract][Full Text] [Related]
6. A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy.
Bies RD; Maeda M; Roberds SL; Holder E; Bohlmeyer T; Young JB; Campbell KP
J Mol Cell Cardiol; 1997 Dec; 29(12):3175-88. PubMed ID: 9441825
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations.
Huizing M; Rakocevic G; Sparks SE; Mamali I; Shatunov A; Goldfarb L; Krasnewich D; Gahl WA; Dalakas MC
Mol Genet Metab; 2004 Mar; 81(3):196-202. PubMed ID: 14972325
[TBL] [Abstract][Full Text] [Related]
8. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
Moore SA; Saito F; Chen J; Michele DE; Henry MD; Messing A; Cohn RD; Ross-Barta SE; Westra S; Williamson RA; Hoshi T; Campbell KP
Nature; 2002 Jul; 418(6896):422-5. PubMed ID: 12140559
[TBL] [Abstract][Full Text] [Related]
9. WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding.
Chung W; Campanelli JT
Mol Cell Biol Res Commun; 1999; 2(3):162-71. PubMed ID: 10662592
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition by LARGE is essential for expression of functional dystroglycan.
Kanagawa M; Saito F; Kunz S; Yoshida-Moriguchi T; Barresi R; Kobayashi YM; Muschler J; Dumanski JP; Michele DE; Oldstone MB; Campbell KP
Cell; 2004 Jun; 117(7):953-64. PubMed ID: 15210115
[TBL] [Abstract][Full Text] [Related]
12. [Dystroglycan linkage and muscular dystrophy].
Shimizu T
Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
[TBL] [Abstract][Full Text] [Related]
13. The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.
Rentschler S; Linn H; Deininger K; Bedford MT; Espanel X; Sudol M
Biol Chem; 1999 Apr; 380(4):431-42. PubMed ID: 10355629
[TBL] [Abstract][Full Text] [Related]
14. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
[TBL] [Abstract][Full Text] [Related]
15. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
Matsumura K; Saito F; Yamada H; Hase A; Sunada Y; Shimizu T
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):751-62. PubMed ID: 10541473
[TBL] [Abstract][Full Text] [Related]
16. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
[TBL] [Abstract][Full Text] [Related]
17. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex.
Sciandra F; Bozzi M; Bianchi M; Pavoni E; Giardina B; Brancaccio A
Ann Ist Super Sanita; 2003; 39(2):173-81. PubMed ID: 14587215
[TBL] [Abstract][Full Text] [Related]
18. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
Côté PD; Moukhles H; Lindenbaum M; Carbonetto S
Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
[TBL] [Abstract][Full Text] [Related]
19. Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo.
Sotgia F; Bonuccelli G; Bedford M; Brancaccio A; Mayer U; Wilson MT; Campos-Gonzalez R; Brooks JW; Sudol M; Lisanti MP
Biochemistry; 2003 Jun; 42(23):7110-23. PubMed ID: 12795607
[TBL] [Abstract][Full Text] [Related]
20. The role of dystroglycan, a novel receptor of laminin and agrin, in cell differentiation.
Matsumura K; Yamada H; Saito F; Sunada Y; Shimizu T
Histol Histopathol; 1997 Jan; 12(1):195-203. PubMed ID: 9046055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
